Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease.

Yamamoto K, Shimada H, Koh H, Ataka S, Miki T.

Geriatr Gerontol Int. 2014 Jul;14(3):716-23. doi: 10.1111/ggi.12147. Epub 2013 Sep 11.

PMID:
24020590
2.

Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.

Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV.

J Alzheimers Dis. 2011;24(1):25-34. doi: 10.3233/JAD-2010-101248.

3.

The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.

Giedraitis V, Sundelöf J, Irizarry MC, Gårevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L.

Neurosci Lett. 2007 Nov 12;427(3):127-31. Epub 2007 Sep 20.

PMID:
17936506
4.

Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Laske C, Stransky E, Fritsche A, Eschweiler GW, Leyhe T.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):80-5. doi: 10.1007/s00406-008-0838-3. Epub 2008 Sep 19.

PMID:
18806919
5.

Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.

Takeda S, Sato N, Uchio-Yamada K, Yu H, Moriguchi A, Rakugi H, Morishita R.

Dement Geriatr Cogn Disord. 2012;34(1):25-30. doi: 10.1159/000338704. Epub 2012 Aug 9.

PMID:
22889768
6.

Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.

Santos AN, Ewers M, Minthon L, Simm A, Silber RE, Blennow K, Prvulovic D, Hansson O, Hampel H.

J Alzheimers Dis. 2012;29(1):171-6. doi: 10.3233/JAD-2012-111361.

PMID:
22214781
7.

Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.

Watt AD, Perez KA, Faux NG, Pike KE, Rowe CC, Bourgeat P, Salvado O, Masters CL, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2011;24(1):47-59. doi: 10.3233/JAD-2010-101722.

PMID:
21157020
8.

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.

Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A.

Neurobiol Aging. 2011 Dec;32(12):2320.e15-32. doi: 10.1016/j.neurobiolaging.2010.04.028. Epub 2010 Jun 9.

PMID:
20538374
9.

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.

Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Andreasson U, Zetterberg H, Blennow K, Svensson J.

J Alzheimers Dis. 2011;24(3):537-46. doi: 10.3233/JAD-2011-101878.

PMID:
21297262
10.

The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.

Sancesario GM, Cencioni MT, Esposito Z, Borsellino G, Nuccetelli M, Martorana A, Battistini L, Sorge R, Spalletta G, Ferrazzoli D, Bernardi G, Bernardini S, Sancesario G.

J Alzheimers Dis. 2012;31(4):865-78. doi: 10.3233/JAD-2012-120211.

PMID:
22717612
11.

Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease.

Sorensen KC, Simonsen AH, Holmetoft UB, Hasselbalch SG, Heegaard NH.

J Alzheimers Dis. 2013;37(2):379-87. doi: 10.3233/JAD-122410. Erratum in: J Alzheimers Dis. 2014;40(4):1063.

PMID:
23948879
12.

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.

Frankfort SV, Tulner LR, van Campen JP, Verbeek MM, Jansen RW, Beijnen JH.

Curr Clin Pharmacol. 2008 May;3(2):123-31. Review.

PMID:
18700307
13.

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.

Lewczuk P, Esselmann H, Groemer TW, Bibl M, Maler JM, Steinacker P, Otto M, Kornhuber J, Wiltfang J.

Biol Psychiatry. 2004 Mar 1;55(5):524-30.

PMID:
15023581
14.

No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.

Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De Leenheir E, Martin JJ, Vanmechelen E, Van Broeckhoven C, De Deyn PP.

Brain. 2007 Sep;130(Pt 9):2320-6. Epub 2007 Jun 22.

PMID:
17586559
15.

Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.

Krishnan S, Rani P.

Biol Trace Elem Res. 2014 May;158(2):158-65. doi: 10.1007/s12011-014-9930-x. Epub 2014 Mar 30.

PMID:
24682919
16.

Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.

He J, Qiao JP, Zhu S, Xue M, Chen W, Wang X, Tempier A, Huang Q, Kong J, Li XM.

Curr Alzheimer Res. 2013 Nov;10(9):979-86.

PMID:
24117120
17.

Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis.

Zhou L, Chan KH, Chu LW, Kwan JS, Song YQ, Chen LH, Ho PW, Cheng OY, Ho JW, Lam KS.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):697-702. doi: 10.1016/j.bbrc.2012.06.017. Epub 2012 Jun 12.

PMID:
22704931
18.

Age and its association with low insulin and high amyloid-β peptides in blood.

Li H, Zhu H, Wallack M, Mwamburi M, Abdul-Hay SO, Leissring MA, Qiu WQ.

J Alzheimers Dis. 2016;49(1):129-37. doi: 10.3233/JAD-150428.

19.

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.

Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L.

J Alzheimers Dis. 2010;21(2):471-8. doi: 10.3233/JAD-2010-091594.

PMID:
20555147
20.

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.

Wang T, Xiao S, Liu Y, Lin Z, Su N, Li X, Li G, Zhang M, Fang Y.

Int J Geriatr Psychiatry. 2014 Jul;29(7):713-9. doi: 10.1002/gps.4053. Epub 2013 Dec 7.

PMID:
24318929

Supplemental Content

Support Center